Neuromersiv is thrilled to be announced as one of eleven high-impact health tech startups as part of the MedTech Actuator accelerator program’s fourth cohort.

Supported by Australian Industry Growth Centre, MTPConnect and a plethora of ecosystem partners, the fourth cohort of companies will be put through their paces in a rigorous industry-led 15-month program. They will accelerate technology development, build team capability and develop the skills and knowledge for entrepreneurial success. Along with training, mentoring and connectivity to 75+ local and global industry partners, the program provides access to a structured pathway to $3million+ Seed to Series A investment, with venture partners Artesian.

Neuromersiv featured on Prime7 Tamworth
NBN News features Neuromersiv's upcoming hospital trials
Categories: News

Leave a Reply

Your email address will not be published. Required fields are marked *